Skip to main content

Day: January 15, 2020

Talmora Diamond Inc. Exploration Update

TORONTO, Jan. 15, 2020 (GLOBE NEWSWIRE) — Talmora Diamond Inc. (CSE: TAI) (“Talmora” or the Company”) is pleased to provide an exploration update.As previously reported, the field portion of the 2019 drill program on the Seahorse Project located in Canada’s Northwest Territories (the “Seahorse Project”) ended in late September.  Encouraging results from this program warrant additional work. Six holes were drilled to test certain regional geophysical targets that had been confirmed and further delineated by a detailed helimag program that was conducted during April and May 2019.  The six holes were drilled to a maximum depth of 316’ using a reverse circulation, heli portable drill. Each of the holes intersected varying depths of extremely fine-grained clays that do not...

Continue reading

GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome

SARASOTA, Fla. and NOVATO, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) — GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare diseases, today announced that GeneTx’s Investigational New Drug (IND) Application for GTX-102, an experimental antisense oligonucleotide being evaluated for the treatment of Angelman syndrome (AS), filed with the U.S. Food and Drug Administration (FDA) is now active. Enrollment in the Phase 1/2 study is expected to begin in the first half of 2020.“The FDA’s clearance of the IND to evaluate GTX-102 in patients with Angelman syndrome represents a significant milestone for the Angelman community,” said Paula Evans, Chief Executive Officer at GeneTx.  “Assessing...

Continue reading

Capital Southwest Announces Third Quarter Fiscal Year 2020 Earnings Release and Conference Call Schedule

DALLAS, Jan. 15, 2020 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it will release its third quarter 2020 results on Monday, February 3, 2020 after the market closes.  In conjunction with the release, Capital Southwest has scheduled a conference call which will be broadcast live via phone and over the Internet on Tuesday, February 4, 2020 at 11:00 a.m. Eastern time.  Investors may participate either by phone or audio webcast.By Phone:Dial (866)-502-8274 and provide the operator with Conference ID 1477718 at least 10 minutes before the call.  A replay...

Continue reading

Melcor REIT declares January, February and March distributions, unchanged from previous months; announces Q4-2019 conference call details

EDMONTON, Alberta, Jan. 15, 2020 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (TSX: MR.UN) today announced that the Trustees of the REIT have declared cash distributions of $0.05625 per unit for the months of January, February and March 2020, unchanged from previous months.The January, February and March distributions will be payable as follows:Melcor REIT also announced that results for fourth quarter and year ended December 31, 2019 will be released on Thursday, March 5, 2020 after market close. Management will host a conference call at 11:00 am ET (9:00 am MT) on Friday, March 6, 2020.Q4 Conference CallToronto area: 416-340-2216Toll free: 1-800-377-0758Webcast & ReplayThe call will also be webcast (listen only) at www.gowebcasting.com/10462. A replay of the call will be available at the same URL shortly after the...

Continue reading

QYOU Media Announces Share Compensation

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO and LOS ANGELES, Jan. 15, 2020 (GLOBE NEWSWIRE) — QYOU Media Inc. (TSXV: QYOU; OTCQB: QYOUF) (“QYOU Media” or the “Company”) announced today that, in recognition of the fact that the directors of the Company have not received cash remuneration for their services as directors since the Company’s shares began trading on the TSX Venture Exchange following its reverse take-over transaction on March 31, 2017, the Company intends to issue an aggregate of 4,315,832 common shares of the Company to its non-management directors, as compensation for such services. Such compensation shares will be issued at a deemed issuance price of $0.10 per share. Pursuant to agreements between the Company and its non-management...

Continue reading

Global Water Announces Proposed Public Offering of Common Stock

PHOENIX, Jan. 15, 2020 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares are being offered by the company. In addition, the company expects to grant the underwriter for the offering a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.The company anticipates using the net proceeds from the offering to fund acquisitions and for working capital...

Continue reading

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATIONMontrouge, France, January 15, 2020Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with ODDO BHF.Under the liquidity contract between DBV Technologies and ODDO BHF, the following assets appeared on the liquidity account as of December 31st, 2019:9,000 DBV Technologies shares€ 1,051,48.5.14When the agreement was first put in place, the following assets appeared on the liquidity account:41,159 DBV Technologies shares;€ 432,367.25Over the period from 01/07/2019 to 31/12/2019 were executed:1,367 purchase transactions1,452 transactions for saleOver the same period, the volumes traded represented:276,797...

Continue reading

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

Informations RéglementéesMontrouge, France, le 15 janvier (22h00 CET), 2020Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHFDBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique français, publie aujourd’hui le bilan semestriel de son contrat de liquidité avec ODDO BHF.Au titre du contrat de liquidité confié à ODDO BHF, portant sur les actions de la société DBV TECHNOLOGIES, à la date du 31 décembre 2019, les moyens suivants figuraient au compte de liquidité :9 000 titres DBV Technologies ;1 051 485,14 euros.Lors de la mise en place du contrat, les moyens suivants figuraient au compte de liquidité :41 159 titres DBV Technologies ;432 367,25...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.